Browsing Tag
BRUIN CLL-314
1 post
Eli Lilly’s Jaypirca outpaces Imbruvica in landmark CLL head‑to‑head trial
Eli Lilly’s Jaypirca beats Imbruvica in a head-to-head CLL trial. Explore why this breakthrough matters for BTK therapy and cancer care.